rCBV values can serve as a powerful indication of IDH wildtype vs IDH mutant gliomas, as recent studies have found these values to be 2–2.5 higher in IDH wildtype glioma samples than their IDH mutant counterparts [237]. This evidence concerns the gene IDH2 and central nervous system cancer.